Samsara BioCapital, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 75 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$606,000
-36.4%
488,6320.0%0.15%
-17.3%
Q4 2021$953,000
-28.8%
488,6320.0%0.18%
-11.9%
Q3 2021$1,339,000
-42.0%
488,632
-33.3%
0.21%
-26.3%
Q2 2021$2,308,000
-40.8%
732,596
-60.0%
0.28%
-60.4%
Q1 2021$3,901,000
+22.6%
1,831,490
+11.7%
0.72%
+124.7%
Q4 2020$3,182,0001,640,3680.32%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders